clarithromycin martindale pharma 500 mg powder for concentrate for solution for infusion
martindale pharmaceuticals ltd - clarithromycin - pdr/conc/soln for infus - 500 milligram(s) - macrolides; clarithromycin
klariger 250 milligram film coated tablet
mcdermott laboratories ltd t/a gerard laboratories - clarithromycin - film coated tablet - 250 milligram - macrolides
clarithromycin
accord healthcare limited - clarithromycin - film coated tablet - 250 milligram - clarithromycin
clarithromycin
accord healthcare limited - clarithromycin - film coated tablet - 500 milligram - clarithromycin
clarie xl 500mg tablets
teva uk ltd - clarithromycin - modified-release tablet - 500mg
clarithromycin teva 250 mg film-coated tablets
teva pharma b.v. - clarithromycin - film-coated tablet - 250 milligram(s) - macrolides; clarithromycin
clarithromycin teva 500 mg film-coated tablets
teva pharma b.v. - clarithromycin - film-coated tablet - 500 milligram(s) - macrolides; clarithromycin
klariger 500 mg film-coated tablets
mcdermott laboratories ltd., t/a gerard laboratories - clarithromycin - film-coated tablet - 500 milligram(s) - macrolides; clarithromycin
minatev la
teva pharma b.v. - clarithromycin - tablet prolonged release - 500 milligram - clarithromycin
klacid forte 500 mg film-coated tablets
mylan ire healthcare limited - clarithromycin - film-coated tablet - 500 milligram(s) - macrolides; clarithromycin - antibacterial for systemic use, macrolide - it is indicated for treatment of infections due to susceptible organisms. such infections include. 1. lower respiratory tract infections (e.g. bronchitis, pneumonia). 2. upper respiratory tract infections (e.g. pharyngitis, sinusitis). 3. skin and soft tissue infections (e.g. folliculitis, cellulitis, erysipelas). 4. disseminated or localised mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare. localised infections due to mycobacterium chelonae, mycobacterium fortuitum or mycobacterium kansasii. 5. is indicated also for the prevention of disseminated mycobacterium avium complex infection in hiv- infected patients with cd4 lymphocyte counts less than or equal to 100/mm3. 6. in the presence of acid suppression is indicated for the eradication of h. pylori, resulting in decreased recurrence of duodenal ulcer.